secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001104659-25-118934
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics prices $150M public offering of 6M shares at $25/sh
-------------------------------------------------------------------------

- Offering 6,000,000 shares at $25.00 per share; expected gross proceeds ~$150M.
- Underwriters granted 30-day option to purchase up to 900,000 additional shares.
- Net proceeds for product candidate development, manufacturing, working capital, and corporate purposes.
- Joint book-running managers: Piper Sandler & Co. and Oppenheimer & Co.; co-manager: H.C. Wainwright & Co.
- Offering expected to close on or about December 8, 2025, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/0001104659-25-118934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000110465925118934/capr-20251205x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-118934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer